All categoriesARA-290BPC-157GHK-CULARAZOTIDEPENTADECA-ARGINATETB-500
Category
Healing & Tissue Repair
Compounds studied for their role in wound healing, angiogenesis, and connective-tissue remodeling.
Healing & Tissue Repair
ARA-290
Cibinetide
- MW
- 1257.3 g/mol
- Half-life
- ≈ 2 min (plasma), prolonged receptor effect
- Class
- Innate repair receptor agonist (EPO-derived peptide)
Healing & Tissue Repair
BPC-157
Body Protection Compound 157 · PL 14736
- MW
- 1419.5 g/mol
- Half-life
- ≈ 30 min (plasma, preclinical)
- Class
- Pentadecapeptide fragment of gastric BPC
Healing & Tissue Repair
GHK-Cu
Copper Tripeptide-1
- MW
- 402.92 g/mol (complex)
- Half-life
- Short (topical/local activity)
- Class
- Copper-binding tripeptide
Healing & Tissue Repair
Larazotide
AT-1001 · Larazotide acetate
- MW
- 726.8 g/mol
- Half-life
- Minimal systemic absorption (acts luminally)
- Class
- Tight-junction regulator (zonulin antagonist)
Healing & Tissue Repair
Pentadeca Arginate
PDA · BPC-157 arginate salt · PDA-157
- MW
- ≈ 1419 g/mol (peptide portion)
- Half-life
- Reported longer than acetate form; not formally characterised
- Class
- Arginate-stabilised pentadecapeptide
Healing & Tissue Repair
TB-500
Thymosin Beta-4 fragment
- MW
- ≈ 889 g/mol (fragment)
- Half-life
- 2–3 h (preclinical)
- Class
- Synthetic fragment of Thymosin β4